Citations

Showing 10 of 108094 citations.

Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report
Ruff, Michael W. , Gompel, Jaimie J. Van, Uhm, Joon H. , Himes, Benjamin , Park, Sean S. , Galanis, Evanthia , Kaufmann, Timothy J.

Mayo Clinic

Journal of Neurosurgery | April 27, 2018 | Volume: 130 | Issue: 4 | Pages: 1299-1303

10.3171/2017.11.jns172373 | PMID 29701552 Get It

The authors present the case of a man with a papillary craniopharyngioma, first diagnosed at 47 years of age, who experienced multiple recurrences. Review of the pathologic specimen from his first resection demonstrated the BRAF V600E mutation. With his most recent recurrence following previous surgery and radiotherapy, at 52 years of age, the decision was made to initiate treatment with the BRAF V600E inhibitor dabrafenib. Imaging following initiation of dabrafenib demonstrated reduction in tumor size. He remained on dabrafenib therapy for approximately 1 year and continued to demonstrate a good clinical result. At that time the decision was made to discontinue dabrafenib therapy and follow up with serial imaging. After more than 1 year of follow-up since stopping dabrafenib, the patient has continued to do well with no radiographic evidence of tumor progression and continues to be monitored with frequent interval imaging.
The Complexity and Heterogeneity of Monoclonal Immunoglobulin–Associated Renal Diseases
Sethi, Sanjeev , D’Agati, Vivette D. , Rajkumar, S. Vincent

Mayo Clinic

Journal of the American Society of Nephrology | April 27, 2018 | Volume: 29 | Issue: 7 | Pages: 1810-1823

10.1681/asn.2017121319 | PMID 29703839 Get It

Monoclonal gammopathies are characterized by the overproduction of monoclonal Ig (MIg) detectable in the serum or urine resulting from a clonal proliferation of plasma cells or B lymphocytes. The underlying hematologic conditions range from malignant neoplasms of plasma cells or B lymphocytes, including multiple myeloma and B-cell lymphoproliferative disorders, to nonmalignant small clonal proliferations. The term MGUS implies presence of an MIg in the setting of a “benign” hematologic condition without renal or other end organ damage. The term MGRS was recently introduced to indicate monoclonal gammopathy with MIg-associated renal disease in the absence of hematologic malignancy. Most MIg-associated renal diseases result from the direct deposition of nephrotoxic MIg or its light- or heavy-chain fragments in various renal tissue compartments. Immunofluorescence microscopy is essential to identify the offending MIg and define its tissue distribution. Mass spectrometry is helpful in difficult cases. Conditions caused by direct tissue deposition of MIg include common disorders, such as cast nephropathy, amyloidosis, and MIg deposition diseases, as well as uncommon disorders, such as immunotactoid glomerulopathy, proliferative GN with MIg deposits, light-chain proximal tubulopathy, and the rare entities of crystal-storing histiocytosis and crystalglobulinemia. Indirect mechanisms of MIg-induced renal disease can cause C3 glomerulopathy or thrombotic microangiopathy without tissue MIg deposits. Treatment of MIg-associated renal disease is aimed at eliminating the clonal plasma cell or B-cell population as appropriate. Both the renal and the underlying hematologic disorders influence the management and prognosis of MIg-associated renal diseases.
1143 Sleep Evaluation Highlights Subtleties of Dyspnea
Baig, Hassan , Colaco, Brendon, Dredla, Brynn K., Arunthari, Vichaya, Baig, Hassan Z

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A422-A423

10.1093/sleep/zsy063.1142 Get It

1140 Multiple Sleep Related Disorders and Their Interplay in a Complicated Case
Baig, Hassan , Colaco, Brendon, Arunthari, Vichaya, Colaco, Clinton , Dredla, Brynn K., Baig, Hassan Z

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A421-A422

10.1093/sleep/zsy063.1139 Get It

1112 Trazodone responsive Agrypnia
Hernandez, Meylin Lam, Dredla, Brynn K., Castillo, Pablo R.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A413-A413

10.1093/sleep/zsy063.1111 Get It

1105 Ophthalmic Conditions and Sleep Apnea-Hypopnea Syndrome: Uncharted Territory
Kwon, Minkyung , Arunthari, Vichaya, Willey, Drew, Colaco, Brendon, Mansukhani, Meghna P.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A410-A411

10.1093/sleep/zsy063.1104 Get It

1106 A Walk on the Beach May Become What the Doctor Recommends
Kwon, Minkyung , Colaco, Brendon, Willey, Drew, Dredla, Brynn K., Arunthari, Vichaya, Castillo, Pablo R.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A411-A411

10.1093/sleep/zsy063.1105 Get It

0472 Effect Of Alcohol On Sleep-disordered Breathing In Snorers Versus Non-snorers:a Systematic Review And Meta-analysis
Saeidifard, Farzane , Chakravorty, Subhajit , Foroughi, Mahnoosh , Kolla, Bhanu Prakash , Mansukhani, Meghna P.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A178-A178

10.1093/sleep/zsy061.471 Get It

0485 Effectiveness of WatchPAT Test to Evaluate Adequacy of Treatment Response with Oral Appliance for Obstructive Sleep Apnea
Contreras, Jaimie, Anders, G, Pena-Orbea, Ciythya, Escalante, Patricio , Patel, Salma , Patel, I

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A183-A183

10.1093/sleep/zsy061.484 Get It

0504 Predictive Ability And Reliability Of The Stop-Bang Questionnaire In Screening For Obstructive Sleep Apnea In Midlife Women
Orbea, Cinthya Peña, Lloyd, Robin M. , Kapoor, Ekta , Miller, Virginia M. , Kapoor, Ekta , Mara, Kristin C. , Faubion, Stephanie S.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A189-A189

10.1093/sleep/zsy061.503 Get It